Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kellee Swider

Physician Assistant Marrero, LA Physician Assistant

NPI 1265822878 CMS profile 10692315

4513 Westbank Expressway, Marrero, LA 70072

Open in the dashboard

General payments

$9,563

418 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kellee Swider of Marrero, LA is reported in the CMS Open Payments database as having received $9,563 across 418 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19 1
2024 General $16 1
2023 General $4,190 177
2022 General $4,329 193
2021 General $1,009 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kellee Swider
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Kellee Swider were reported at $19. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Kellee Swider Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,009 $132 $37–$438 $132
2022 $4,329 $155 $48–$522 $149
2023 $4,190 $167 $52–$557 $160
2024 $16 $178 $55–$600 $164
2025 $19 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novartis Pharmaceuticals Corporation $1,132 43 payments
  2. E.R. Squibb & Sons, L.L.C. $591 23 payments
  3. AstraZeneca Pharmaceuticals LP $571 21 payments
  4. Janssen Biotech, Inc. $517 27 payments
  5. Incyte Corporation $513 18 payments
  6. Merck Sharp & Dohme Corporation $415 24 payments
  7. Pfizer Inc. $411 19 payments
  8. Genentech USA, Inc. $399 20 payments
  9. Genzyme Corporation $381 20 payments
  10. Gilead Sciences, Inc. $362 12 payments
  11. Other $4,271 191 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,666 405 payments
  2. Long term medical supply or device loan $499 5 payments
  3. Education $294 7 payments
  4. Consulting Fee $105 1 payment
Products named General payments · program years 2021–2025
  1. OPDIVO $448 15 payments
  2. KEYTRUDA $415 24 payments
  3. KISQALI $391 14 payments
  4. BRUKINSA $360 10 payments
  5. Trodelvy $346 11 payments
  6. Lenvima $287 18 payments
  7. JAKAFI $277 10 payments
  8. JEVTANA $277 11 payments
  9. IMBRUVICA $269 8 payments
  10. DARZALEX $266 11 payments
  11. Other $7,459 371 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

418 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record